Literature DB >> 11791180

Paxillin null embryonic stem cells are impaired in cell spreading and tyrosine phosphorylation of focal adhesion kinase.

Ramon Wade1, Joanna Bohl, Scott Vande Pol.   

Abstract

Paxillin is a focal-adhesion associated protein implicated in the regulation of integrin signaling and organization of the actin cytoskeleton. Paxillin associates with numerous signaling molecules including adaptor molecules (p130Cas, CRK), kinases (FAK, Pyk2, PAK and SRC), tyrosine phosphatases (PTP-PEST), ARF-GAP proteins (p95pkl, PAG3) and papillomavirus E6 oncoproteins. Although paxillin is tyrosine phosphorylated in cellular processes such as cell attachment and spreading, little direct evidence is available about paxillin's role in these events. Targeted gene disruption was used to generate paxillin null mouse embryonic stem (ES) cells and paxillin null differentiated cells. Paxillin null ES cells exhibit delayed spreading on integrin binding substrates fibronectin and laminin, and there is reduced tyrosine phosphorylation of Focal Adhesion Kinase (FAK). Both of these phenotypes are recovered in paxillin knockout cells upon exogenous re-expression of paxillin. The individual LD motifs of paxillin that are binding sites for FAK, vinculin and ARF-GAP proteins, as well as tyrosine residues that when phosphorylated create binding sites for CRK family members, are dispensable for FAK phosphorylation and early cell spreading. These results demonstrate that paxillin contributes to attachment-dependent tyrosine phosphorylation of FAK and early cell spreading in ES cells.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11791180     DOI: 10.1038/sj.onc.1205013

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  38 in total

Review 1.  Extracellular matrix, junctional integrity and matrix metalloproteinase interactions in endothelial permeability regulation.

Authors:  J S Alexander; John W Elrod
Journal:  J Anat       Date:  2002-06       Impact factor: 2.610

2.  Transformation by bovine papillomavirus type 1 E6 requires paxillin.

Authors:  Ramon Wade; Nicole Brimer; Scott Vande Pol
Journal:  J Virol       Date:  2008-04-02       Impact factor: 5.103

3.  Mutations in the paxillin-binding site of integrin-linked kinase (ILK) destabilize the pseudokinase domain and cause embryonic lethality in mice.

Authors:  Daniel Moik; Anika Böttcher; Tatiana Makhina; Carsten Grashoff; Nada Bulus; Roy Zent; Reinhard Fässler
Journal:  J Biol Chem       Date:  2013-05-08       Impact factor: 5.157

4.  Paxillin regulates androgen- and epidermal growth factor-induced MAPK signaling and cell proliferation in prostate cancer cells.

Authors:  Aritro Sen; Katherine O'Malley; Zhou Wang; Ganesh V Raj; Donald B Defranco; Stephen R Hammes
Journal:  J Biol Chem       Date:  2010-07-13       Impact factor: 5.157

5.  Paxillin contracts the osteoclast cytoskeleton.

Authors:  Wei Zou; Carl J Deselm; Thomas J Broekelmann; Robert P Mecham; Scott Vande Pol; Kyunghee Choi; Steven L Teitelbaum
Journal:  J Bone Miner Res       Date:  2012-12       Impact factor: 6.741

6.  Minimal features of paxillin that are required for the tyrosine phosphorylation of focal adhesion kinase.

Authors:  Ramon Wade; Scott Vande Pol
Journal:  Biochem J       Date:  2006-01-15       Impact factor: 3.857

Review 7.  Syndecan-4: dispensable or indispensable?

Authors:  Sarah A Wilcox-Adelman; Fabienne Denhez; Tokuro Iwabuchi; Stefania Saoncella; Enzo Calautti; Paul F Goetinck
Journal:  Glycoconj J       Date:  2002 May-Jun       Impact factor: 2.916

8.  Paxillin controls endothelial cell migration and tumor angiogenesis by altering neuropilin 2 expression.

Authors:  Alexandra E German; Tadanori Mammoto; Elisabeth Jiang; Donald E Ingber; Akiko Mammoto
Journal:  J Cell Sci       Date:  2014-02-12       Impact factor: 5.285

9.  Leupaxin, a novel coactivator of the androgen receptor, is expressed in prostate cancer and plays a role in adhesion and invasion of prostate carcinoma cells.

Authors:  Silke Kaulfuss; Michal Grzmil; Bernhard Hemmerlein; Paul Thelen; Stefan Schweyer; Jürgen Neesen; Lukas Bubendorf; Andrew G Glass; Hubertus Jarry; Bernd Auber; Peter Burfeind
Journal:  Mol Endocrinol       Date:  2008-05-01

10.  RNF5, a RING finger protein that regulates cell motility by targeting paxillin ubiquitination and altered localization.

Authors:  Christine Didier; Limor Broday; Anindita Bhoumik; Sharon Israeli; Shoichi Takahashi; Koh Nakayama; Sheila M Thomas; Christopher E Turner; Scott Henderson; Hisataka Sabe; Ze'ev Ronai
Journal:  Mol Cell Biol       Date:  2003-08       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.